Latest Australian Government News

Echo IQ has secured a $1.26 million refund under the Australian Government's R&D Tax Incentive, reinforcing its commitment to AI-driven solutions for structural heart disease detection.

Patronus Resources has initiated an on-market takeover offer for Matsa Resources at $0.045 per share, representing a significant premium and aiming to consolidate its position in gold exploration.

Pilbara Minerals delivers record production and sales at Pilgangoora but faces statutory net losses due to joint venture investments and expansion costs. The company remains optimistic about long-term lithium market prospects.

The Australian Office of Financial Management has issued a new 4.25% Treasury Bond due in 2036, set to begin trading on the ASX from February 13, 2025. This issuance adds a fresh long-term government debt instrument to the market.

Spacetalk Ltd has secured a $428,853 R&D tax rebate from the Australian Taxation Office, reinforcing its commitment to innovation while reporting a 16% increase in Annual Recurring Revenue and significant cost reductions.

Australian Rare Earths Limited (AR3) has obtained South Australian Government approval to expand its Overland Uranium Project, gaining rights over an additional ~1,000km² and greenlighting immediate drilling on high-potential targets.

Biome Australia has partnered with the Food and Beverage Accelerator (FaBA) to jointly develop its promising BMB18 probiotic strain, leveraging $50 million in Australian government funding while retaining full IP ownership.

Lunnon Metals has launched a co-funded diamond drilling program at its high-potential Defiance West target near the historic Victory-Defiance Gold Mine, aiming to unlock new gold mineralisation in a previously untested area.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.

Entyr Limited has received a $3.79 million R&D tax incentive payment for its innovative thermal desorption project targeting rubber waste, reinforcing its position in sustainable tyre recycling technology.

Alterity Therapeutics has raised over A$2 million through its U.S. ATM facility and expects nearly A$5.7 million in Australian tax rebates, fueling the advancement of its lead neurodegenerative drug candidate ATH434 following promising Phase 2 results.

Betashares Capital Ltd has announced the final distribution amounts for its suite of funds for the January 2025 period, outlining key dates and eligibility for unitholders.